SCHEMBL6978415

SCHEMBL6978415

N=C1CCCCC(C(C[N+](=O)[O-])c2ccccc2)N1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.41
NPC1 O15118 1/20 0.35
ADAM17 P78536 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CPA1 P15085 3/20 0.33
CNR2 P34972 1/20 0.33
SLC6A2 P23975 3/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 3/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(2-Nitrovinyl)Benzene SCHEMBL8152119 0.89 FBP1 (0.42) CNR1MEN1KMT2AMAPK1NPSR1
SCHEMBL6974269 0.89 CNR1 (0.41) CNR1NPC1ADAM17MEN1KMT2A
SCHEMBL6972340 0.89 ALDH1A1 (0.43) CNR1NPC1MEN1KMT2ACNR2
SCHEMBL6969217 0.80 SLC6A2 (0.36) MEN1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL6977300 0.80 KMT2A (0.45) CNR1MEN1KMT2AKDM4EMAPT
SCHEMBL6974041 0.78 SLC6A3 (0.35) CNR1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL6970982 0.75 MEN1 (0.35) MEN1KMT2ASLC6A2SLC6A4SLC6A3
Trifluoroacetic Acid SCHEMBL6979873 0.74 MEN1 (0.37) NPC1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL813507 0.74 CA1 (0.53) CNR1NPC1ADAM17KDM4EMAPT
SCHEMBL809451 0.74 CA1 (0.53) CNR1NPC1ADAM17KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed